Edwards Lifesciences Corp (EW) Key Ratios
$89.82
As on 04-Sep-2026 13:44EDT
Market cap
$51,764 Mln
Revenue (TTM)
$6,512 Mln
P/E Ratio
53.5
P/B Ratio
4.9
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 5.60 | 13.63 | 14.55 | 6.30 | 5.75 |
| EBIT | -- | -- | -44.97 | -16.47 | -11.58 |
| Net Profit | -36.33 | -26.12 | -75.74 | -4.76 | -6.96 |
| EPS | -36.12 | -25.34 | -75.16 | -8.52 | -5.70 |
| Book Value | -- | -- | 4.94 | 23.54 | 19.68 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| 25.12 | 28.34 | 13.79 | 20.98 | 28.82 |
| Net Margin
| -- | 28.32 | 15.43 | -- | -- |
| Return on equity
| 27.74 | 27.65 | 9.60 | 10.56 | 50.15 |
| Return on Capital
| 25.48 | 25.06 | -- | 9.88 | 46.30 |
| Return on Assets
| 20.38 | 19.68 | 6.64 | 8.03 | 37.24 |
| Debt to Equity (x)
| -- | -- | 0.06 | 0.07 | 0.07 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
9.88
|
46.30
|
20.28
|
23.37
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
9.60
Higher than Peers by 4.66
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
9.60
|
10.56
|
50.15
|
22.52
|
26.14
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
6.64
Higher than Peers by 4.19
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
6.64
|
8.03
|
37.24
|
15.89
|
18.12
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
13.79
Higher than Peers by 5.31
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
13.79
|
20.98
|
28.82
|
25.55
|
33.32
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
15.43
Higher than Peers by 10.75
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
15.43
|
17.69
|
76.75
|
23.35
|
28.08
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
14.55
Higher than Peers by 6.07
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
14.55
|
0.12
|
-0.09
|
0.12
|
0.03
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-44.97
Lower than Peers by 55.62
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
-44.97
|
-18.81
|
2.20
|
-14.47
|
3.87
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
-75.74
Lower than Peers by 89.29
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
-75.74
|
-74.28
|
197.68
|
-7.85
|
1.25
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
-75.16
Lower than Peers by 95.67
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
-75.16
|
-0.74
|
2.06
|
-0.06
|
0.04
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
2.48
Lower than Peers by 4.52
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
2.48
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.06
Lower than Peers by 0.34
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
0.06
|
0.07
|
0.07
|
0.10
|
0.12
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.00
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
0.00
|
0.00
|
0.00
|
0.00
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
4.52
Higher than Peers by 1.70
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
4.52
|
3.72
|
4.18
|
3.38
|
3.03
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
3.77
Higher than Peers by 1.73
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
3.77
|
3.09
|
3.45
|
2.62
|
2.17
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
62.40
|
79.19
|
87.16
|
68.46
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
14.68
Lower than Peers by 1.78
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
14.68
|
15.03
|
13.37
|
13.79
|
12.99
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.43
Lower than Peers by 0.07
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
0.43
|
0.45
|
0.49
|
0.68
|
0.64
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
49.35
|
52.22
|
46.45
|
46.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
304.57
|
325.24
|
235.46
|
250.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
58.48
|
62.75
|
51.42
|
63.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
295.43
|
314.71
|
230.49
|
233.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
53.51
Higher than Peers by 9.05
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
53.51
|
46.20
|
10.47
|
33.00
|
30.21
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
4.93
Higher than Peers by 1.14
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
4.93
|
4.80
|
4.37
|
6.96
|
7.92
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
29.54
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
29.54
|
32.23
|
23.47
|
29.55
|
23.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
51,764
Higher than Peers by 51,224
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
|
51,764
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|